The Scientist

» amyloid plaques

Most Recent

image: More Evidence of Alzheimer’s Transmission

More Evidence of Alzheimer’s Transmission

By | January 27, 2016

Examining the brains of seven patients who died of the prion disease called Creutzfeldt–Jakob, researchers find signs of Alzheimer’s pathology. 

1 Comment

image: Delayed Turnover

Delayed Turnover

By | July 21, 2015

Aggregate-forming amyloid β proteins are replenished more slowly with age, and this may contribute to a person's risk of developing Alzheimer’s disease.

0 Comments

image: Shoring Up Golgi To Slow Alzheimer’s

Shoring Up Golgi To Slow Alzheimer’s

By | December 8, 2014

Blocking activity of a kinase in a mouse model protects Golgi in cells and reduces the build-up of amyloid β, a primary component of Alzheimer’s disease.

0 Comments

image: Week in Review: May 12–16

Week in Review: May 12–16

By | May 16, 2014

Antidepressant could prevent Alzheimer’s plaques; 12,000-year-old human skeleton sequenced; disentangling the mystery of octopus arms; taking a look at the ocular microbiome

0 Comments

image: Autophagy’s Role in Alzheimer’s

Autophagy’s Role in Alzheimer’s

By | October 3, 2013

Researchers show that amyloid beta is secreted from neurons in an autophagy-dependent manner.

0 Comments

image: Cancer Drug for Alzheimer’s Disappoints

Cancer Drug for Alzheimer’s Disappoints

By | May 24, 2013

Researchers have been unable to reproduce findings that a cancer drug destroys amyloid beta plaques.

0 Comments

image: Restless Nights Predict Alzheimer’s?

Restless Nights Predict Alzheimer’s?

By | October 19, 2012

Researchers find that disrupted sleep-wake cycles could reflect or even contribute to the neurodegenerative disease.

2 Comments

image: Ready for Prime Time

Ready for Prime Time

By | February 1, 2012

Biomarkers of Alzheimer’s disease are ready for widespread use in clinical trials.

1 Comment

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech